ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,027.11
0.23%
US Tech 100
21,013.40
-0.14%
다우존스 지수
43,677.45
0.57%
Bitcoin
94,390.46
-1.96%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Inhibrx Biosciences Inc (INBX) 시세

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INBX)

NASDAQ
12.48
-0.08
( -0.64% )
업데이트: 03:29:20
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
12.48
매수가
12.33
매도가
12.58
거래량
49,691
12.03 일간 변동폭 13.065
10.80 52주 범위 39.79
market_cap
180.659M
전일 종가
12.56
개장가
13.065
최근 거래 시간
22
@
12.605
마지막 거래 시간
03:29:20
재정 규모
US$ 616,400
VWAP
12.4047
평균 볼륨(3m)
81,118
발행 주식
14,475,904
배당수익률
-
주가수익률
-1.15
주당순이익(EPS)
-10.71
매출
1.63M
순이익
-154.96M

Inhibrx Biosciences Inc 정보

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.inhibrx.com
본부
Wilmington, Delaware, USA
설립됨
-
Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker INBX. The last closing price for Inhibrx Biosciences was US$12.56. Over the last year, Inhibrx Biosciences shares have traded in a share price range of US$ 10.80 to US$ 39.79.

Inhibrx Biosciences currently has 14,475,904 shares in issue. The market capitalisation of Inhibrx Biosciences is US$181.82 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.15.

INBX 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
01 6월 2024
INBX (-0.64%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
31 5월 2024
INBX (-0.64%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.07-7.8966789667913.5514.3812.035287012.81445858CS
4-0.64-4.8780487804913.1214.3811.798496813.00118137CS
12-2.655-17.542120911815.13516.8311.798111813.93494386CS
26-1.01-7.4870274277213.4917.7911.798596114.83109375CS
52-25.73-67.338393090838.2139.7910.826595728.35736317CS
156-7.99-39.032730825620.4739.797.6741605524.87470469CS
260-7.22-36.649746192919.750.977.6733378725.76945777CS

INBX - Frequently Asked Questions (FAQ)

What is the current Inhibrx Biosciences share price?
The current share price of Inhibrx Biosciences is US$ 12.48
How many Inhibrx Biosciences shares are in issue?
Inhibrx Biosciences has 14,475,904 shares in issue
What is the market cap of Inhibrx Biosciences?
The market capitalisation of Inhibrx Biosciences is USD 181.82M
What is the 1 year trading range for Inhibrx Biosciences share price?
Inhibrx Biosciences has traded in the range of US$ 10.80 to US$ 39.79 during the past year
What is the PE ratio of Inhibrx Biosciences?
The price to earnings ratio of Inhibrx Biosciences is -1.15
What is the cash to sales ratio of Inhibrx Biosciences?
The cash to sales ratio of Inhibrx Biosciences is 108.77
What is the reporting currency for Inhibrx Biosciences?
Inhibrx Biosciences reports financial results in USD
What is the latest annual turnover for Inhibrx Biosciences?
The latest annual turnover of Inhibrx Biosciences is USD 1.63M
What is the latest annual profit for Inhibrx Biosciences?
The latest annual profit of Inhibrx Biosciences is USD -154.96M
What is the registered address of Inhibrx Biosciences?
The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Inhibrx Biosciences website address?
The website address for Inhibrx Biosciences is www.inhibrx.com
Which industry sector does Inhibrx Biosciences operate in?
Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
STECSantech Holdings Limited
US$ 1.8226
(180.27%)
108.24M
YYAIConnexa Sports Technologies Inc
US$ 1.41
(120.28%)
123.19M
PEPGPepGen Inc
US$ 2.73
(99.27%)
102.11M
RETOReTo Eco Solutions Inc
US$ 0.7202
(77.43%)
67.05M
GSUNGolden Sun Health Technology Group Ltd
US$ 3.74
(41.13%)
2.52M
THTarget Hospitality Corporation
US$ 4.77
(-49.04%)
8.89M
NKLANikola Corporation
US$ 0.2578
(-32.16%)
37.63M
CHSNChanson International Holding
US$ 0.258
(-29.59%)
4.06M
STAIScanTech AI Systems Inc
US$ 2.3257
(-29.31%)
3.47M
WDCWestern Digital Corporation
US$ 49.195
(-28.40%)
7.65M
NVDANVIDIA Corporation
US$ 134.55
(0.09%)
153.04M
PLTRPalantir Technologies Inc
US$ 93.39
(-7.85%)
131.74M
YYAIConnexa Sports Technologies Inc
US$ 1.41
(120.28%)
123.19M
CNEYCN Energy Group Inc
US$ 0.262
(7.11%)
110.41M
STECSantech Holdings Limited
US$ 1.8226
(180.27%)
108.24M

INBX Discussion

게시물 보기
Monksdream Monksdream 4 월 전
INBX under $20
👍️0
Monksdream Monksdream 5 월 전
INBX under $20
👍️0
Monksdream Monksdream 6 월 전
INBX under $15
👍️0
Monksdream Monksdream 11 월 전
INBX over $30
👍️0
TrendTrade2016 TrendTrade2016 2 년 전
heres the dolla...boom!!
👍️0
TrendTrade2016 TrendTrade2016 2 년 전
INBX DOLLA RUMMER IN PROCESS
👍️0
TrendTrade2016 TrendTrade2016 2 년 전
INBX...PRE MARKET VOL
👍️0
Jaydixson1 Jaydixson1 2 년 전
Seems to be dropping
👍️0
make it happen make it happen 2 년 전
Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

Profitability
Profit Margin 0.00%
Operating Margin -1,448.76%

Management Effectiveness
Return on Assets -37.98%
Return on Equity -562.25%

Income Statement
Revenue 7.03M
Revenue Per Share 0.18
Quarterly Revenue Growth (yoy) -25.50%
Gross Profit -64.21M
EBITDA -100.6M
Net Income Avi to Common -110.75M
Diluted EPS -2.44

Balance Sheet
Total Debt 175.7M
Book Value Per Share -0.13

Cash Flow Statement
Operating Cash Flow -90.16M
Levered Free Cash Flow -46.31M
👍️0

최근 히스토리

NASDAQ
INBX
Inhibrx Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지